• Puma Biotech Gains After Rival Drug Data Show No Threat
  • Merck KGaA Doesn’t Rule Out Pursuing Lung-Cancer Vaccine
  • Billionaire Frost Props Up Prolor Bid With Stock Buys
  • U.S. Stock Options With Biggest Changes in Implied Volatility
  • Gene-Testing Dispute Focuses on How Much a Patient Should Know
  • ReNeuron Plans to Report Stroke Patients Helped, CEO Says
  • Roche Experimental Leukemia Drug Helps Shrink Tumors
  • Glenview Capital Mgmt Inc Holdings in 1st Quarter: 13F Alert
  • Sirios Capital Management Holdings in 1st Quarter: 13F Alert
  • Bayer, Algeta Win U.S. Approval for Prostate Cancer Drug
  • BASF Reaches Enzyme-Platform Licensing Accord With Dyadic
  • Manatt, Jones Day, Howrey, Ropes & Gray: Business of Law
  • Roche Wins FDA Approval for Test to Target Lung Cancer
  • Primecap Rides Health to Top Growth Fund: Riskless Return
  • Jolie Has Double Mastectomy to Thwart Cancer Gene Risk
« Previous 1 2 Next »